Optiscan has been featured in Stockhead regarding the completion of the beta testing phase of its innovative cloud-based technology platform.

The article highlights the potential impact the platform can have in the advancement of digital pathology by enabling real-time remote collaboration on patient imaging.

"This will enable medical devices to seamlessly transmit high-quality images to the cloud as they are captured, allowing pathologists and clinicians to collaborate instantly regardless of their location."

Read the full article here.